ABCB1 and neoplasm: Previous work has indicated that these compounds are also active against cell lines and tumours resistant to other chemotherapeutic regimens, including those which express P-glycoprotein (Day et al, 2003; Suzuki et al, 2003; Newman et al, 2008).